14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of APVO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Aptevo Therapeutics Inc as stock downgraded to Sell Candidate.
(Updated on Apr 23, 2024)

Sell candidate since Apr 23, 2024 PDF

The Aptevo Therapeutics Inc stock price gained 3.69% on the last trading day (Tuesday, 23rd Apr 2024), rising from $0.710 to $0.736. During the last trading day the stock fluctuated 9.23% from a day low at $0.700 to a day high of $0.765. The price has fallen in 8 of the last 10 days and is down by -77.42% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 182 thousand more shares were traded than the day before. In total, 345 thousand shares were bought and sold for approximately $254.17 thousand.

Given the current short-term trend, the stock is expected to rise 64.41% during the next 3 months and, with a 90% probability hold a price between $1.21 and $13.60 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

APVO Signals & Forecast

Aptevo Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aptevo Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.744 and $3.39. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -88.85%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Aptevo Therapeutics Inc stock

Aptevo Therapeutics Inc finds support from accumulated volume at $0.727 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0646 between high and low, or 9.23%. For the last week, the stock has had daily average volatility of 8.93%.

Aptevo Therapeutics Inc is oversold on RSI14 (10). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (APVO) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Aptevo Therapeutics Inc to open at $0.734, and during the day (based on 14 day Average True Range), to move between $0.271 and $1.20, which gives a possible trading interval of +/-$0.465 (+/-63.16%) up or down from last closing price. If Aptevo Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 126.33% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.727 (1.20%) than the resistance at $0.768 (4.32%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aptevo Therapeutics Inc stock A Buy?

The Aptevo Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Aptevo Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.136 Sell Candidate Downgraded

Predicted Opening Price for Aptevo Therapeutics Inc of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$0.734 ( 0.353%) $0.736

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for APVO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.798 8.42 %
R2 0.774 5.07 %
R1 0.758 3.00 %
Current price: 0.736
Support S1 0.709 -3.71 %
S2 0.694 -5.78 %
S3 0.669 -9.13 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.85 14.79 %
R2 0.783 6.36 %
R1 0.768 4.32 %
Current price 0.736
Support S1 0.727 -1.20%
S2 0.713 -3.22%
S3 0.710 -3.56%

FAQ

What is the symbol for Aptevo Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Aptevo Therapeutics Inc is APVO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aptevo Therapeutics Inc Stock?
The Aptevo Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Aptevo Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Aptevo Therapeutics Inc Stock?
Aptevo Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aptevo Therapeutics Inc Stock.

What's the current price of Aptevo Therapeutics Inc Stock?
As of the end of day on the Apr 23, 2024, the price of an Aptevo Therapeutics Inc (APVO) share was $0.736.

What is the 52-week high and low for Aptevo Therapeutics Inc Stock?
The 52-week high for Aptevo Therapeutics Inc Stock is $10.80 and the 52-week low is $0.125.

What is the market capitalization of Aptevo Therapeutics Inc Stock?
As of the Apr 23, 2024, the market capitalization of Aptevo Therapeutics Inc is 495.779K.

When is the next earnings date for Aptevo Therapeutics Inc?
The upcoming earnings date for Aptevo Therapeutics Inc is May 09, 2024.
Click to get the best stock tips daily for free!

About Aptevo Therapeutics Inc

Aptevo Therapeutics Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational ... APVO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT